Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Voyager Therapeutics is a biotechnology company focused on developing gene therapies for neurological diseases. Utilizing proprietary platforms like TRACER for blood-brain barrier crossing, it advances treatments for Alzheimer’s, Parkinson’s, Friedreich’s ataxia, and other CNS disorders. The company collaborates with industry partners, licensing innovative capsids and antibody technologies to create disease-modifying medicines targeting genetic and protein pathways in the brain.
This description was generated via AI from an annual report. Updated about 1 year ago.